Zhang Qiuxiang, Cheng Qiuhan, Cui Shumao, Zhao Jianxin, Chen Wei, Zhang Hao
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, Jiangsu, China.
School of Food Science and Technology, Jiangnan University, Wuxi, 214122, Jiangsu, China.
Arch Microbiol. 2022 May 11;204(6):315. doi: 10.1007/s00203-022-02896-9.
Gardnerella vaginalis is the core pathogen of bacterial vaginosis (BV), the most common vaginal infection in women. G. vaginalis exerts pathogenicity through various factors, such as biofilm formation and the local host immune response stimulation. Therefore, this study aimed to evaluate the inhibitory effect of Lactobacillus gasseri CCFM1201 on G. vaginalis using experimental BV models. We evaluated L. gasseri in vitro to inhibit pathogen biofilm formation and adhesion capacity in HeLa cells using crystal violet staining. Further in vivo studies were conducted to assess the inhibitory effects of L. gasseri CCFM1201 on BV induced by G. vaginalis. L. gasseri exhibited strain-specific adhesion and inhibition of pathogen biofilm formation in vitro. L. gasseri CCFM1201 significantly reduced G. vaginalis in mice (p < 0.05), inhibited sialidase activity, modulated tumor necrosis factor-α and interleukin-1β expression, and reduced myeloperoxidase activity (p < 0.05). Histopathological examination indicated that L. gasseri CCFM1201 improved inflammatory cell infiltration of vaginal tissue and restored its structure. Vaginal epithelial cell exfoliation, the main clinical feature of BV, was significantly improved by L. gasseri CCFM1201 intervention (p < 0.05). Thus, L. gasseri CCFM1201 is a potential candidate for treating G. vaginalis-induced vaginal diseases.
阴道加德纳菌是细菌性阴道病(BV)的核心病原体,细菌性阴道病是女性中最常见的阴道感染。阴道加德纳菌通过多种因素发挥致病性,如生物膜形成和刺激局部宿主免疫反应。因此,本研究旨在使用实验性BV模型评估加氏乳杆菌CCFM1201对阴道加德纳菌的抑制作用。我们使用结晶紫染色在体外评估了加氏乳杆菌对HeLa细胞中病原体生物膜形成和黏附能力的抑制作用。进一步进行体内研究以评估加氏乳杆菌CCFM1201对阴道加德纳菌诱导的BV的抑制作用。加氏乳杆菌在体外表现出菌株特异性黏附以及对病原体生物膜形成的抑制作用。加氏乳杆菌CCFM1201显著降低了小鼠体内的阴道加德纳菌数量(p < 0.05),抑制了唾液酸酶活性,调节了肿瘤坏死因子-α和白细胞介素-1β的表达,并降低了髓过氧化物酶活性(p < 0.05)。组织病理学检查表明,加氏乳杆菌CCFM1201改善了阴道组织的炎性细胞浸润并恢复了其结构。加氏乳杆菌CCFM1201干预显著改善了BV的主要临床特征——阴道上皮细胞脱落(p < 0.05)。因此,加氏乳杆菌CCFM1201是治疗阴道加德纳菌引起的阴道疾病的潜在候选菌株。